The U.S. Government Developed A Key Green Technology. The

New Post Public Reply Private Reply Replies (0) Message Board
energy_wave energy_wave #94101
260
The U.S. Government Developed A Key Green Technology. The Biden Admin Gave It To China.



Quote:
The Department of Energy’s Inspector General is reviewing why the Joe Biden administration gave promising battery technology, developed by taxpayer dollars, to a Chinese company instead of making the batteries in the U.S.

China is now reportedly building one of the largest battery grids in the world using the technology, which could store huge amounts of solar energy without degrading over time or requiring lithium, mitigating a major environmental impact of current green technology that ends up in landfills.

In 2021, there was an “illicit Department of Energy (DOE) transfer of a fifteen million dollar, taxpayer-funded advanced battery technology to China,” Sens. John Barrasso (R-WY) and Joni Ernst (R-IA) wrote in a letter to the DOE’s internal watchdog.

The company that received the license “plainly stated on their official website that they planned to manufacture the batteries in China,” even though the license included “a requirement that the batteries be ‘substantially manufactured’ in the U.S. As these stipulations were continuously violated, DOE never raised any concern,” they wrote.

“We are concerned that this is an overt dereliction of duty by DOE, and that this case may be emblematic of a department that routinely and flippantly permits government-funded technology to be transferred to China,” the senators concluded.

In response, Inspector General Teri L. Donaldson replied this month that “we are conducting a thorough review of this matter.”

In August, NPR reported that U.S. government-funded scientists working at the Pacific Northwest National Laboratory had developed the “vanadium redox flow battery,” which could store enough energy to power a house and last for 30 years. The technology would make it easier to rely on solar power.

The U.S. government holds the patent on the technology, and in 2012, it licensed it to Gary Yang, one of the scientists who helped develop it, so that he could commercialize it. He launched a firm called UniEnergy Technology, but it ran into funding problems, NPR reported.

In 2017, Yang — an American citizen who was born in China — obtained a sublicense from the DOE to allow a Chinese firm to make the batteries. In 2021, he transferred the license outright to a Dutch company called Vanadis Power, which said it would make the batteries in China but eventually move production to Europe to comply with European rules.

America had those rules too, but seemed less strict about enforcing them. On July 7, 2021, UniEnergy emailed a government manager at the Pacific Northwest National Laboratory to request approval to transfer the license to Vanadis, and within 90 minutes, the government granted approval, even though Vanadis’ website said it would make the batteries in China.

Unnamed DOE officials told NPR they often rely on “good faith disclosures” — in other words, the honor system.

But an American company, Forever Energy, told NPR that they had been telling the DOE that the license was out of compliance, only to be shrugged off.

After questions from NPR, the DOE revoked the license, potentially freeing it up for an American company like Forever Energy.

But a Forever executive said now the U.S. is far behind, and that she doubts China will stop producing the technology simply because it no longer has the license.

Last month, Ernst said that taxpayer-funded tech breakthroughs routinely end up in the hands of China, and that a confidential Department of Defense report went so far as to say “China, not the U.S., is the ultimate beneficiary of DoD and other [U. S. Government] research investments.”


https://www.dailywire.com/news/the-u-s-govern...t-to-china
big-wave_surfing_01.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 42

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 309

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 84

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 92

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Farmmi Receives Extension to Comply with NASDAQ Requirements

Updated Category News Views 64

Farmmi Secures NASDAQ Compliance Extension Farmmi, Inc. (NASDAQ: FAMI), a supplier of agricultural products, has been granted a 180-day extension by NASDAQ to meet its crucial minimum bid price requirement. This extension allows the company until the spring of 2025 to elevate its ordinary share bid price to at least $1.00 for at least ten consecutive business days. The...

Continue Reading
The Neurotechnology Surge: $57B Market by 2034

Updated Category News Views 16

Neurotechnology: The Rising Giant Elbows on the table, let's chew the fat about neurotechnology. The market, dizzyingly projected to soar past USD 57 billion by 2034, is on an explosive trajectory. Folk wiser than us predict an annual growth rate hanging around 14%. This ain't just whispers in coffee shops; it's cold, hard data from DelveInsight’s Market Insights...

Continue Reading
Reviva Pharmaceuticals' New Phase 3 Study for Schizophrenia Drug

Updated Category News Views 99

Reviva Pharmaceuticals' Regulatory Update Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) has recently provided an update regarding their journey with brilaroxazine, a novel drug aimed at treating schizophrenia. This news comes after a pre-New Drug Application meeting with the U.S. Food and Drug Administration (FDA). About Brilaroxazine Brilaroxazine is an innovative...

Continue Reading
Lowe's Reports Strong Earnings Amid Strategic Acquisitions

Updated Category News Views 117

Strong Q2 Earnings Surprise Lowe’s Companies Inc (NYSE: LOW) experienced better-than-expected second quarter earnings, bringing a burst of optimism for investors. The home improvement giant saw its stock increase by approximately 2% shortly after announcing its Q2 financial results. Having recorded solid performance through the quarter, Lowe’s exceeded analysts'...

Continue Reading
Invideo and Kling AI Unite for Game-Changing Visuals

Updated Category News Views 153

Invideo and Kling AI Collaborate to Redefine Video Editing Invideo has recently partnered with Kling AI to introduce an exciting tool known as VFX House. This innovative feature empowers creators with studio-level control for their video projects, offering enhanced capabilities for both marketing and editorial work. Unlocking New Possibilities with VFX House The...

Continue Reading